The new coronavirus at the end of 2019 is common enemy all mankind. rapid spread ofthe COVID-19 pandemic poses a huge challenge to global public health security. At present, globalizationgoes far beyond economic activity and embraces political, cultural, environmental healthsecurity spheres. Deepening globalization has led an unprecedented acceleration in movementof goods people across borders,...

The novel coronavirus or COVID-19 is a new highly infectious virus affecting large population across the globe. There no specific therapeutic drug available against covid-19 hence most effective public health measures need to strictly be adhered without delay. Range of issues were reported fight in current system Nepal which should addressed and strengthened full spectrum for its sustainable re...

www.thelancet.com/infection Vol 14 June 2014 443 recommendations. Because this was a phase 2 trial that was not powered for comparison of regimens, a phase 3 trial is needed to compare the two doses of raltegravir in patients co-infected with HIV and tuberculosis. In the interim, despite fi ndings from the pharmacokinetic study in healthy volunteers showing a reduction in raltegravir trough con...